AI and its Impact on Healthcare by Ray Kurzweil

AI and its Impact on Healthcare by Ray Kurzweil

On the last day (April, 2) of the outstanding NextMed Health 2025 event – https://www.nextmed.health/, another famous exponent of innovation in health took part: Ray Kurzweil.

He participated live, online, from Boston, and here are some of his views on the exponential growth of AI and its impact on health and medicine.

  • 75,000-fold increase in computational power since 1939, predicting AI will achieve AGI by 2029.
  • AI is revolutionizing healthcare by repurposing drugs, developing new drugs, and enhancing surgical robots.
  • By 2035, AI will simulate entire bodies, accelerating drug but human testing remains crucial.
  • AI advancements will reverse aging, reducing death risk.
  • There will be an integration of AI with human biology, expanding human intelligence by 2045.
  • He acknowledges the downsides of AI, such as privacy concerns and the need for ethical considerations but remains optimistic about its potential benefits.
  • Kurzweil stressed the importance of preparing for these advancements in education and healthcare.

Some action items:

  • Explore the use of large language models to assist with sensitive health discussions and data collection.
  • Investigate the potential for AI-driven drug repurposing to overcome the slow process of new drug approvals.
  • Follow up on the recent example of AI-generated drug for idiopathic pulmonary fibrosis that reached phase IIa clinical trials.
  • Discuss the implications of AI-powered surgical robots, such as the Star system, and their potential to perform remote surgeries.
  • Consider the impact of brain-computer interfaces on the future of healthcare and how they can be integrated into everyday life.
  • Explore the feasibility of simulating entire biological systems, including organs and the human body, to accelerate drug testing and personalized treatments.

See this article also on Linkedin: Click Here!

You can Share on:

LinkedIn
Facebook
X
WhatsApp

Specis

As the Director of SPECIS, a health consulting firm operating in Brazil and internationally, Dr. Fernandes collaborates with leading institutions, corporations, health tech companies, and governmental bodies.

Recent Posts

  • All Post
  • Artificial Intelligence
  • Clinical Validation
  • Digital Health
  • Genes
  • Professional Activities
  • Telemedicine
  • The Future of Medicine

Dr. Jefferson

Dr. Jefferson G Fernandes is a Neurologist, educator, and global leader in digital health, bridging the gap between innovation and real-world healthcare transformation.

Category

  • Artificial Intelligence
  • Clinical Validation
  • Digital Health
  • Genes
  • Professional Activities
  • Telemedicine
  • The Future of Medicine

Other Blog Posts

Prof Partridge Oct25
The Future of Medicine

Healthy Longevity and Artificial Intelligence

At the end of October 2025, Professor Dame Linda Partridge went to Porto Alegre, Brazil, to participate in another edition of The Future of Medicine event. I took the opportunity to have a conversation with

Read More